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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
To compare the two regional techniques of thoracic epidural blockade (TEB) and paravertebral block (PVB) in adults undergoing
elective thoracotomy with respect to:
1. analgesic efficacy;
2. the incidence of major complications (including mortality);
3. the incidence of minor complications;
4. length of hospital stay;
5. cost effectiveness.
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B A C K G R O U N D
Description of the condition
Operations on structures in the chest (usually the lungs) involve
cutting between the ribs (thoracotomy). Post-thoracotomy pain
results from pleural (lung lining) and muscular damage, costover-
tebral joint (ribcage) disruption and intercostal nerve (nerves that
run along the ribs) damage during surgery (Ng 2007). It is one of
the most severe types of postoperative pain. Poor pain relief can
lead to immobility and ineffective breathing and clearing of secre-
tions, resulting in susceptibility to lung collapse (atelectasis), chest
infections (pneumonia) and blood clots (pulmonary embolism)
(Richardson 1994). The risk of respiratory complications has been
reported to be between 15% and 32.5% (D’Arsigny 1998; Wang
1999) and has been observed to account for more than half of the
30-day mortality after surgery to remove a lung (Powell 2009). In
the same observational study, cardiac arrhythmias were reported
in 20% of patients (Powell 2009). Pain relief after thoracic surgery
is therefore important for patient comfort and for reduction of
postoperative pulmonary and cardiac complications.
Pain can often persist after thoracotomy and the incidence of
chronic pain is high, with studies revealing that 30% to 50% of
patients still experience pain up to five years after surgery (De
Cosmo 2009; Rogers 2000). The exact mechanism of chronic
post-thoracotomy pain is unknown but intercostal nerve damage
at thoracotomy is believed to be a major factor, as demonstrated
by neurophysiological studies (Benedetti 1998). Electromyogra-
phy and somatosensory evoked responses demonstrated that in-
tercostal nerve damage led to decreased pain threshold of the op-
erative scar. A ’wind up’ phenomenon of repeated stimulation of
peripheral nerve fibres can cause a wide range of nerve fibres to
become hyperexcitable and is associated with chronic pain. Ag-
gressive management of acute pain following thoracotomy may
reduce the likelihood of developing chronic pain (Katz 1996). A
multi-modal approach to analgesia is widely employed by thoracic
anaesthetists using a combination of regional anaesthetic blockade
and systemic analgesia, with both non-opioid and opioid medica-
tions and local anaesthesia blockade.
There is some evidence that blocking the nerves as they emerge
from the spinal column (paravertebral block) maybe associated
with a lower risk ofmajor complications in thoracic surgery but the
majority of thoracic anaesthetists still prefer to use a thoracic epidu-
ral as analgesia for their patients undergoing thoracotomy. Previ-
ous systematic reviews of analgesic techniques in thoracic surgery
have only evaluated short-term complications (Davies 2006; Joshi
2008; Kotze 2009). In order to bring about a change in prac-
tice, anaesthetists need a review that evaluates the risk of all major
complications associated with thoracic epidural and paravertebral
block in thoracotomy.
Description of the intervention
Thoracic epidural blockade
Thoracic epidural blockade (TEB) using local anaesthetic and opi-
oid agents has been widely regarded as the gold standard for anal-
gesia and the reduction of associated complications following tho-
racotomy.Good analgesia from an epidural can result in early extu-
bation, better ventilatorymechanics and gas exchange and reduced
rates of lung collapse, pneumonia and pain (De Cosmo 2009).
However, the technique requires highly trained medical staff not
only for insertion and removal of the epidural catheter but also for
the management of the continuous infusion of pain medication.
The risks associated with insertion of the epidural include acci-
dental dural puncture, inadvertent high block, local anaesthetic
toxicity and total spinal anaesthesia (inadvertent spinal injection
of an epidural dose of local anaesthetic leading to local anaesthetic
depression of the cervical spinal cord and the brainstem). Nerve
injury, epidural haematoma and abscess are rare but serious com-
plications. The UK National Audit Project led by the Royal Col-
lege of Anaesthetists reported a low rate of permanent harm from
all central blocks of 4.2 per 100,000, with rates twice as high in
epidurals compared other central neuraxial blocks (Cook 2009). A
thoracic epidural blocks nerves bilaterally and sympathetic nerve
block can result in hypotension due to both vasodilatation and
cardiac depression. This requires cautious fluid administration in
order to avoid fluid overload in susceptible patients (Marret 2005).
Failure rates have been described as from 14% to 30% and can be
influenced by the skills of the practitioner inserting the catheter
and accidental dislodgement of the catheter (Davies 2006).
An epidural is not a suitable technique for all patients and is
contraindicated in patients with local infection, previous spinal
surgery, disorders of blood clotting and in those taking anti-coag-
ulant and anti-platelet therapy. The epidural is inserted through
the skin rather than placed under vision and requires a highly
skilled practitioner to perform the technique. Trained staff are also
needed to look after the patients postoperatively in order to avoid
accidental dislodgement of catheters and to observe for side ef-
fects. These staff add to the cost of the technique to the healthcare
system.
Paravertebral blockade
Paravertebral block (PVB) involves injecting local anaesthetic into
the paravertebral space to block nerves after leaving the spinal
cord. PVB can be given as a ’single shot’ technique but is often
given as a continuous infusion of local anaesthetic via a catheter
placed directly through the skin (percutaneously) or under direct
vision during thoracotomy. Thoracic paravertebral anaesthesia has
a number of advantages over the thoracic epidural technique. PVB
is a one-side (unilateral) technique and so respiratory and sympa-
thetic function is preserved on the other (contralateral) side (Ng
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2007) and this may be associated with less hypotension, fewer pul-
monary complications and less urinary retention (Davies 2006).
The failure rate in adults has been reported as 10.1% (Lonnqvist
1995; Richardson 1999) and significantly lower than TEB (OR
0.28, P = 0.007) (Davies 2006). The complications reported in-
clude inadvertent vascular puncture (3.8% to 6.8%); hypotension
(4.0% to 4.6%); haematoma (2.4%); pain at site of skin punc-
ture (1.3%); signs of epidural or intrathecal spread (1.0%); pleural
puncture (0.8% to 1.1%); and pneumothorax (0.5%) (Lonnqvist
1995; Naja 2001). Recent evidence suggests that short-term side
effects such as hypotension, urinary retention, nausea, and vom-
iting appear to be less frequent with PVB than with TEB (Daly
2009). The effect of paravertebral anaesthesia on blood pressure
and heart rate is minimal, making this technique safe for patients
with coexisting circulatory disease. PVB is thought to be associ-
ated with better pulmonary function and fewer pulmonary com-
plications than TEB (Joshi 2008; Richardson 1999). Contraindi-
cations to thoracic epidural analgesia do not preclude PVB, which
can also be safely performed in anaesthetized patients without an
apparent increased risk of neurological injury.
How the intervention might work
The primary purpose of both these techniques is to achieve good
postoperative analgesia. They employ the same pharmacological
agents and both have been shown to produce important benefits
in this clinical setting. This review is less concerned with the mode
of action of PVB than with the ease of use, broad applicability,
and relative safety of this technique. Technically, PVB is easier to
perform than TEB, needle placement for paravertebral block is
away from the midline and spinal cord (Richardson 1999), and
some patients who are unsuitable for TEB may be suitable for
PVB.
Why it is important to do this review
TEB using local anaesthetic and opioid has been widely regarded
as the gold standard for analgesia and reduction of the associ-
ated complications after thoracotomy. A survey of Australian tho-
racic anaesthetists in 1997 revealed that 79% regarded TEB as
the method of choice for analgesia in thoracotomy (Cook 1997).
Similar results were found in the UK with 80% of anaesthetists
considered TEB as the best mode of pain relief for upper abdomi-
nal surgery (Cook Eaton 1997). Recent evidence from two meta-
analyses and systematic reviews comparing the analgesic efficacy
and side effects of epidural versus paravertebral blockade for tho-
racotomy pain control concluded that although the analgesia was
comparable, paravertebral blockade had a better short-term side
effect profile, including urinary retention, hypotension, nausea
and vomiting, and pulmonary complications (Davies 2006; Joshi
2008). The reviews suggest that paravertebral blockade may be su-
perior to an epidural, but these reviews did not evaluate the more
serious complications including mortality. A 2008 survey of all 38
thoracic units in the UK that was carried out by the Association of
Cardiothoracic Anaesthetists (ACTA) reported that the majority
of thoracic anaesthetists (2/3 units) prefer TEB to PVB, which
suggests that most thoracic anaesthetists have yet to be convinced
by the evidence available (Shelley 2008).
Compared to TEB, PVB may have several practical advantages.
In patients on anti-coagulants or anti-platelet therapy, PVB can
be placed with little concern about epidural haematoma, abscess,
or neurological injury (Daly 2009; Luyet 2009). The catheter can
be placed in the correct position under the direct guidance of the
surgeon, ensuring accurate placement without damage to neu-
rovascular structures or the pleura. Postoperative management of
epidural infusion requires a specialized unit or ward whilst PVB
can be managed on an ordinary ward (Daly 2009; Luyet 2009).
PVB can be used in a higher proportion of patients and reduces
their hospital stay, thereby reducing costs as well as improving the
quality of patient care and satisfaction.
A large prospective multi-centre investigation into analgesic tech-
niques and morbidity following elective pneumonectomy for can-
cer (Powell 2009) shows that TEBwas associated with more major
complications (including significant arrhythmias or pulmonary
complications requiring treatment or ventilator support, unex-
pected intensive care unit (ICU) admissions, 30-day mortality,
further surgery, inotrope usage) than PVB (odds ratio adjusted for
patient and perioperative factors of 2.2, 95% confidence interval
1.1 to 3.8; P = 0.02) (Powell 2009). A comprehensive review of
the existing evidence is needed to establish whether paravertebral
block is associated with lower risk of major complications and to
clarify whether further randomized trials are justified.
O B J E C T I V E S
Tocompare the two regional techniques of thoracic epidural block-
ade (TEB) and paravertebral block (PVB) in adults undergoing
elective thoracotomy with respect to:
1. analgesic efficacy;
2. the incidence of major complications (including mortality);
3. the incidence of minor complications;
4. length of hospital stay;
5. cost effectiveness.
M E T H O D S
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Criteria for considering studies for this review
Types of studies
Wewill only include randomized controlled trials (RCTs). We will
exclude quasi-randomized trials, for example where allocation was
determined by days of the week or hospital number.
Types of participants
We will include all adults undergoing elective thoracotomy in-
cluding for upper gastrointestinal surgery.
Types of interventions
Wewill include continuous thoracic epidural infusions using local
anaesthetics, opioids, and any adjuvant therapies. The comparator
will be continuous paravertebral blockade using local anaesthetics
and adjuvant therapies.
Types of outcome measures
Primary outcomes
1. Mortality to 30 days (we will seek data from the authors and
accept mortality measured at the closest time to 30 days that is
available from each study).
2.Major complications including any of: cardiovascular complica-
tions (systemic hypotension requiring inotropic support, signifi-
cant arrhythmias requiring anti-arrhythmic or cardioversion treat-
ment, myocardial infarction, pulmonary oedema); pulmonary
complications requiring treatment (postoperative ventilatory sup-
port, reintubation for respiratory failure, acute carbon dioxide re-
tention (CO2> 45 mmHg), pneumonia, atelectasis); neurological
complications (delirium); unexpected admission to intensive care;
any complications that lead to further surgery.
Secondary outcomes
3. Analgesic efficacy including pain scores (visual analogue scores),
acute pain, failure of technique, supplemental analgesia,morphine
consumption.
4. Minor complications including hypotension (not requiring in-
otropes), postoperative ileus, excessive sedation, nausea and vom-
iting, pruritis, and urinary retention.
5. Chronic pain at six months and one year.
6. Duration of hospital stay and cost.
Search methods for identification of studies
Electronic searches
We will search for studies on thoracic epidural and paravertebral
blocks in adult patients undergoing thoracotomy in the current
issue of the Cochrane Central Register of Controlled Trials (CEN-
TRAL) (The Cochrane Library); MEDLINE via Ovid (1966 to
date); EMBASE via Ovid (1980 to date); and CINAHL via EB-
SCOhost (1982 to date); trial reference lists; and in conference ab-
stracts. OurMEDLINE search strategy will be found in Appendix
1.
We will limit the results to randomized controlled clinical tri-
als (RCTs) using the Cochrane highly sensitive search strategy
(Higgins 2011). We will not impose a language restriction.
We will combine a free text search with a controlled vocabulary
search, from the inception of a database to the present.
Searching other resources
We will search conference proceedings and abstracts of important
meetings in cardiothoracic surgery and anaesthesia and all efforts
will be made to contact authors and experts in order to identify
unpublished research and trials still underway.
We will handsearch the Journal of Cardiothoracic Surgery and Jour-
nal of Cardiothoracic and Vascular Anesthesia (from 1996 to 2010).
We will also search the databases of on-going trials such as:
http://www.controlled-trials.com/; or
http://clinicaltrials.gov/.
Data collection and analysis
Selection of studies
Two review authors (JY and SG) will screen the abstracts of all
publications obtained by the search strategies. We will note any
reasons for study exclusion in RevMan 5.1. For trials that appear
to be eligible RCTs, we will obtain the full articles to assess their
relevance based on the predefined criteria for inclusion. We will
resolve any disagreement through discussion or, if required, we
will consult FG.
Data extraction and management
We will use a data collection form to extract data (see Appendix
2). For eligible studies, the two review authors (JY and SG) will
extract data independently from original publications onto the
agreed form.We will resolve any disagreement through discussion
or, if required, we will consult FG. As far as possible, we will
contact study authors for important information that is missing
or unclear. We will enter data into RevMan 5.1 and check it for
accuracy.
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Assessment of risk of bias in included studies
Two review authors (JY and SG) will independently assess risk
of bias for each study using the criteria outlined in the Cochrane
risk of bias assessment tool (Higgins 2011). We will resolve any
disagreement through discussion or, if required, we will consult
FG. We will construct a risk of bias table for all included studies
in the review.
(1) Random sequence generation
We will describe for each included study the method used to gen-
erate the random sequence in sufficient detail to allow assessment
of whether it should produce comparable groups.
We will assess the method as:
§ low risk of bias (any truly random process e.g. random number
table, computerized random number sequence)
§ high risk of bias (inadequate generation of randomization se-
quence e.g. consecutive)
§ unclear risk of bias
(2) Allocation concealment (checking for possible selection
bias)
We will describe for each included study the method used to
conceal the allocation sequence in sufficient detail and determine
whether intervention allocation could have been foreseen in ad-
vance of or during recruitment, or changed after assignment.
We will assess the methods as:
§ low risk of bias (e.g. telephone or central randomization; con-
secutively numbered sealed opaque envelopes);
§ high risk of bias (e.g. open random allocation; unsealed or non-
opaque envelopes; alternation; date of birth);
§ unclear.
(3) Blinding (checking for possible performance bias)
We will describe for each included study the methods used, if any,
to blind the study participants personnel and outcome assessment
from knowledge of which intervention a participant received. We
will judge studies to be at low risk of bias if they were blinded, or
if we judge that the lack of blinding could not have affected the
results. We recognize that it may not be possible to blind clinicians
or patients.
We will assess the methods as:
§ low risk of bias, high risk of bias, or unclear risk of bias for
participants;
§ low risk of bias, high risk of bias, or unclear risk of bias for
personnel;
§ low risk of bias, high risk of bias, or unclear risk of bias for
outcome assessors.
(4) Incomplete outcome data (checking for possible attrition
bias through withdrawals, dropouts, protocol deviations)
We will describe for each included study, and for each outcome
or class of outcomes, the completeness of data including attrition
and exclusions from the analysis. We will state whether attrition
and exclusions were reported, the numbers included in the analysis
at each stage (compared with the total number of randomized
participants), the reasons for attrition or exclusion where reported,
and whether missing data were balanced across groups or were
related to outcomes. Where sufficient information is reported, or
can be supplied by trial authors, we will re-include missing data
in the analyses which we undertake.
We will assess the methods as:
§ low risk of bias (where numbers and reasons for attrition, ex-
clusion or re-inclusion have been reported);
§ high-risk of bias (where there are high number of dropouts and
protocol deviations leading to loss of followup);
§ unclear.
(5) Selective reporting bias
Where the original protocol of a study is available (for example as a
separate publication), we will assess whether all of the prespecified
outcomes and analyses were presented.
We will assess the methods as:
§ low risk of bias (where it is clear that all of the study’s prespecified
outcomes and all expected outcomes of interest to the review have
been reported);
§ high-risk of bias (where not all the study’s prespecified outcomes
have been reported, one ormore of the reported primary outcomes
were not prespecified, outcomes of interest were reported incom-
pletely and so cannot be used, the study fails to include results
of a key outcome that would have been expected to have been
reported);
§ unclear.
(6) Other bias
We will describe for each included study any important concerns
we have about other possible sources of bias.
We will assess whether each study was free of other problems that
could put it at risk of bias:
§ low risk of bias
§ high risk of bias;
§ unclear.
(7) Overall risk of bias
We will make explicit judgements about whether studies are at
high risk of bias, according to the criteria given in the Handbook
for Systematic Reviews of Interventions (Higgins 2011). With
reference to (1) to (6) above, wewill assess the likelymagnitude and
direction of the bias and whether we consider it is likely to impact
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on the findings. We will explore the impact of the level of bias
through undertaking sensitivity analyses, see Sensitivity analysis.
Measures of treatment effect
Dichotomous data
For dichotomous data, we will present results as summary risk
ratio with 95% confidence interval.
Continuous data
For continuous data, we will use the mean difference if outcomes
are measured in the same way between trials. We will use the
standardized mean difference to combine trials that measure the
same outcome but use different methods.
Unit of analysis issues
Cluster-randomized trials
We will include cluster-randomized trials in the analyses along
with individually randomized trials. Their sample sizes or standard
errors will be adjusted using the methods described in the Hand-
book, Section 16.3.4 or 16.3.6 (Higgins 2011) using an estimate
of the intracluster correlation coefficient (ICC) derived from the
trial if possible, or from a similar trial or from a study of a similar
population. If ICCs from other sources are used, this will be re-
ported and sensitivity analyses conducted to investigate the effect
of variation in the ICC. If we identify both cluster-randomized
trials and individually-randomized trials, we plan to synthesise the
relevant information. We will consider it reasonable to combine
the results from both if there is little heterogeneity between the
study designs and the interaction between the effect of interven-
tion and the choice of randomization unit is considered to be un-
likely.
We will also acknowledge heterogeneity in the randomization unit
and perform a subgroup analyses to investigate the effects of the
different types of randomization.
Dealing with missing data
For included studies, levels of attrition will be noted. The impact
of including studies with high levels of missing data in the overall
assessment of treatment effect will be explored by using sensitivity
analysis.
For all outcomes, analyses will be carried out, as far as possible, on
an intention-to-treat basis. That is, we will attempt to include all
participants randomized in the analyses and all participants will
be analysed in the group to which they were allocated, regardless
of whether or not they received the allocated intervention.
Assessment of heterogeneity
If substantial heterogeneity is detected we will consider whether
a pooled result would be meaningful and, if it is, we will use a
random-effects model analysis to produce it. We will present the
results of random-effects analyses as the estimated average treat-
ment effect with its 95% confidence interval, and the 95% pre-
diction interval for the underlying treatment effect. We will assess
statistical heterogeneity in each meta-analysis using the I2 and τ
2 statistics. Heterogeneity will be regarded as substantial if the I2
statistic exceeds 30% and either τ 2 is greater than zero, there is a
low P value (< 0.10) in the Chi2 test for heterogeneity, or there is
clearly substantial inconsistency between trials in the direction or
magnitude of effects as judged by visual inspection.
Assessment of reporting biases
If there are 10 or more studies in ameta-analysis we will investigate
reporting biases (such as publication bias) using funnel plots. We
will assess funnel plot asymmetry visually and by formal tests. For
continuous outcomes we will use the test proposed by Egger 1997,
and for dichotomous outcomes the tests proposed by Harbord
2006 or Peters 2006 will be used. If asymmetry is detected by any
of these tests or is suggested by a visual assessment, we will perform
exploratory analyses to investigate it.
Data synthesis
We will carry out statistical analysis using the Review Manager
software (RevMan 5.1). We will use a fixed-effect model meta-
analysis for combining data where it is reasonable to assume that
studies are estimating the same underlying treatment effect. That
is, where trials are examining the same intervention and the trials’
populations and methods are judged to be sufficiently similar. If
there is clinical heterogeneity sufficient to expect that the under-
lying treatment effects differ between trials, or if substantial sta-
tistical heterogeneity is detected, a random-effects model analysis
will be used to produce an overall summary, if this is considered
clinically meaningful. If an average treatment effect across trials
is not clinically meaningful we will not combine heterogeneous
trials. If random-effects analyses are used, the results will present
the average treatment effect and its 95% confidence interval, the
95% prediction interval for the underlying treatment effect, and
the estimates of τ 2 and I2 statistic.
Subgroup analysis and investigation of heterogeneity
If substantial heterogeneity is identified, wewill investigate it using
subgroup and sensitivity analyses.
We will consider whether an overall summary is meaningful and,
if it is, use a random-effects model analysis to produce it. We plan
to carry out the following subgroup analyses.
1. Different types of epidurals (e.g. local anaesthetics with or with-
out added opioid).
2. Different types of surgery (e.g. thoracic surgery, upper gastroin-
testinal surgery).
3. Timing of insertion (before skin incision, after operation).
4. Method of insertion (blind, under ultrasound guidance, under
direct vision).
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5. Other additives used in local anaesthetic mixture (beside local
anaesthetics and opiates).
Only the primary outcome (major complications) will be used in
subgroup analysis.
For fixed-effect inverse variance meta-analysis we will assess the
differences between subgroups by interaction tests implemented
in Revman. For other types of analysis we will conduct interac-
tion tests using mixed effects meta-regression in external statistical
software.
Sensitivity analysis
We will carry out sensitivity analysis to explore the effects of fixed-
effect or random-effects analyses for outcomes with statistical het-
erogeneity and the effects of any assumptions made such as the
value of the ICC used for cluster randomized trials. We will also
use sensitivity analyses to explore the effects of inclusion of studies
at high risk of bias (by assessing the effects of deletion of high
risk studies), and the effects of missing outcome data (by assessing
best case and worst case scenarios, and whether plausible values
of missing data are likely to make a substantial difference to the
results).
Summary of findings tables
Wewill use the principles of the GRADE system (Guyatt 2008) to
assess the quality of the body of evidence associated with specific
outcomes.Wewill include the following as outcomes: cardiovascu-
lar complications, pulmonary complications, critical care admis-
sion, further surgery, 30-day mortality, analgesia efficacy, minor
complications in our review and construct a Summary of Findings
(SoF) table using the GRADE software. The GRADE approach
appraises the quality of a body of evidence based on the extent to
which one can be confident that an estimate of effect or associa-
tion reflects the item being assessed. The quality of a body of evi-
dence considers within study risk of bias (methodologic quality),
the directness of the evidence, heterogeneity of the data, precision
of effect estimates, and risk of publication bias.
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A P P E N D I C E S
Appendix 1. MEDLINE (via Ovid) search strategy
1. exp Analgesia, Epidural/ or exp Anesthesia, Epidural/ or epidural.mp. or expNerveBlock/ or (block adj5 (paravertebral or extrapleural
or subpleural or retropleural or intercostal)).mp. or “Length of Stay”/ or “PostoperativeNausea andVomiting”/ or Arrhythmias, Cardiac/
or Postoperative Complications/ or Cost-Benefit Analysis/ or Pain, Postoperative/
2. Thoracotomy.af. or exp Thoracotomy/
3. 1 and 2
4. ((randomized controlled trial or controlled clinical trial).pt. or randomized.ab. or placebo.ab. or clinical trials as topic.sh. or ran-
domly.ab. or trial.ti.) not (animals not (humans and animals)).sh.
5. 3 and 4
Appendix 2. Data extraction form
Cochrane Anaesthesia Review Group
Study Selection, Quality Assessment and Data Extraction Form
First author Journal/Conference Proceedings etc Year
Study eligibility
RCT Relevant participants Relevant interventions Relevant outcomes
Yes / No / Unclear Yes / No / Unclear Yes / No / Unclear Yes / No* / Unclear
Do not proceed if any of the above answers are ‘No’. If study to be included in ‘Excluded studies’ section of the review, record below
the information to be inserted into ‘Table of excluded studies’.
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Freehand space for comments on study design and treatment:
References to trial
Check other references identified in searches. If there are further references to this trial link the papers now & list below. All references
to a trial should be linked under one Study ID in RevMan.
Code each paper Author(s) Journal/Conference Proceedings etc Year
A
B
Participants and trial characteristics
Participant characteristics
Further details
Age (mean, median, range, etc)
Sex of participants (numbers / %, etc)
Disease status / type, etc (if applicable)
Other
Methodological quality
Allocation of intervention
State here method used to generate allocation and reasons for
grading
Grade (circle)
Low risk of bias
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(Continued)
High risk of bias
Unclear
Concealment of allocation
Process used to prevent foreknowledge of group assignment in a RCT, which should be seen as distinct from blinding
State here method used to conceal allocation and reasons for grad-
ing
Grade (circle)
Low risk of bias
High risk of bias
Unclear
Blinding
Person responsible for participants care Low risk of bias/High risk of bias/Unclear
Participant Low risk of bias/High risk of bias/Unclear
Outcome assessor Low risk of bias/High risk of bias/Unclear
Other (please specify) Low risk of bias/High risk of bias/Unclear
Intention-to-treat
An intention-to-treat analysis is one in which all the participants in a trial are analysed according to the intervention to which they
were allocated, whether they received it or not.
All participants entering trial
15% or fewer excluded
More than 15% excluded
Not analysed as ‘intention-to-treat’
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(Continued)
Unclear
Were withdrawals described? Yes ? No ? not clear ?
Discuss if appropriate
Data extraction
Outcomes relevant to your review
• Denotes primary outcomes
Reported in paper (circle)
Significant arrhythmias* Yes / No
Pulmonary complications including ventilatory support* Yes / No
Unexpected critical care admissions* Yes / No
Further surgery* Yes / No
Inotropic support* Yes / No
30 day mortality* Yes / No
Analgesic efficacy (VAS, morphine, additional analgesia) Yes / No
Nausea & vomiting Yes / No
Failure of technique Yes / No
Urinary retention Yes / No
Duration of hospital stay Yes / No
Cost effectiveness Yes / No
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For Continuous data
Code of paper
Outcomes
Unit of mea-
surement
Intervention group Control group Details if outcome
only described in
text
n Mean (SD) n Mean (SD)
Significant ar-
rhythmias*
Pul-
monary com-
plications/
Ventilator
support*
Un-
expected ICU
admission*
Further
surgery*
Inotropic sup-
port*
30 daymortal-
ity*
Analgesic effi-
cacy
N&V
Failure of
technique
Urinary reten-
tion
Duration of
hospital stay
Cost effective-
ness
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For Dichotomous data
Code of paper Outcomes (rename) Intervention group (n)
n = number of participants, not
number of events
Control group (n)
n = number of participants, not
number of events
A Significant arrhythmias*
Pulmonary complications/ Venti-
lator support*
Unexpected ICU admission*
Further surgery*
Inotropic support*
30 day mortality*
Analgesic efficacy
N&V
Failure of technique
Urinary retention
Duration of hospital stay
Cost effectiveness
Other information which you feel is relevant to the results
Indicate if: any data were obtained from the primary author; if results were estimated from graphs etc; or calculated by you using a
formula (this should be stated and the formula given). In general if results not reported in paper(s) are obtained this should be made
clear here to be cited in review.
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Freehand space for writing actions such as contact with study authors and changes
References to other trials
Did this report include any references to published reports of potentially eligible trials not already identified for this review?
First author Journal / Conference Year of publication
Did this report include any references to unpublished data from potentially eligible trials not already identified for this review? If yes,
give list contact name and details
Trial characteristics
Further details
Single centre / multicentre
Country / Countries
How was participant eligibility defined?
How many people were randomized?
Number of participants in each intervention group
Number of participants who received intended treatment
Number of participants who were analysed
Drug treatment(s) used
Dose / frequency of administration
15Paravertebral block versus thoracic epidural for patients undergoing thoracotomy (Protocol)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
Duration of treatment (State weeks / months, etc, if cross-over
trial give length of time in each arm)
Median (range) length of follow-up reported in this paper (state
weeks, months or years or if not stated)
Time-points when measurements were taken during the study
Time-points reported in the study
Time-points you are using in RevMan
Trial design (e.g. parallel / cross-over*)
Other
* If cross-over design, please refer to the Cochrane Editorial Office for further advice on how to analyse these data
H I S T O R Y
Protocol first published: Issue 5, 2011
C O N T R I B U T I O N S O F A U T H O R S
Conceiving the review: FG
Designing the review: FG, JY, SG
Co-ordinating the review: FG
Undertaking manual searches: JY, SG
Screening search results: JY, SG
Organizing retrieval of papers: JY, SG
Screening retrieved papers against inclusion criteria: JY,SG
Appraising quality of papers: JY, SG
Abstracting data from papers: JY, SG
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Data management for the review: JY
Entering data into Review Manager (RevMan 5.1): JY, SG
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Other statistical analysis not using RevMan: SG
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